Advertisement
Advertisement

IONS

IONS logo

Ionis Pharmaceuticals, Inc. Common Stock

84.03
USD
Sponsored
+0.85
+1.03%
Jul 07, 10:04 UTC -4
Open

IONS Earnings Reports

Positive Surprise Ratio

IONS beat 29 of 42 last estimates.

69%

Next Report

Date of Next Report
Jul 28, 2026
Estimate for Q2 26 (Revenue/ EPS)
$193.32M
/
-$1.11
Implied change from Q1 26 (Revenue/ EPS)
-21.44%
/
+98.21%
Implied change from Q2 25 (Revenue/ EPS)
-57.23%
/
-258.57%

Ionis Pharmaceuticals, Inc. Common Stock earnings per share and revenue

On Apr 29, 2026, IONS reported earnings of -0.56 USD per share (EPS) for Q1 26, beating the estimate of -0.92 USD, resulting in a 39.67% surprise. Revenue reached 246.09 million, compared to an expected 199.54 million, with a 23.33% difference. The market reacted with a +4.25% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 9 analysts forecast an EPS of -1.11 USD, with revenue projected to reach 193.32 million USD, implying an increase of 98.21% EPS, and decrease of -21.44% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Cybin Inc. Common Stock
Report Date
Jun 29, 2026 For Q4 26
Estimate
-$0.91
Actual
-$1.16
Surprise
-27.08%
FAQ
For Q1 2026, Ionis Pharmaceuticals, Inc. Common Stock reported EPS of -$0.56, beating estimates by 39.67%, and revenue of $246.09M, 23.33% above expectations.
The stock price moved up 4.25%, changed from $71.78 before the earnings release to $74.83 the day after.
The next earning report is scheduled for Jul 28, 2026.
Based on 9 analysts, Ionis Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$1.11 and revenue of $193.32M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement